Clinical Trial Update: Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update exploring semaglutide GLP-1 agonists with degludec basal-bolus insulin in early type 1 diabetes (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Degludec (degludec)
• semaglutide (semaglutide)

Snippet

Sponsor: Ministry of Health, Saudi Arabia | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: UNKNOWN